Wird geladen...
The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D
Specialty drugs can bring substantial benefits to patients with debilitating conditions, such as cancer, but their costs are very high. Insurers/payers have increased patient cost-sharing for specialty drugs to manage specialty drug spending. We utilized Medicare Part D plan formulary data to create...
Gespeichert in:
| Veröffentlicht in: | Forum Health Econ Policy |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5877476/ https://ncbi.nlm.nih.gov/pubmed/29610565 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|